Nordfang O, Ezban M, Dinesen B
Thromb Haemost. 1985 Jun 24;53(3):346-50.
Factor VIII coagulant antigen (VIII: CAg) was measured in a sandwich-ELISA. Microplates were used as solid phase and peroxidase conjugated F(ab')2 fragments of IgG isolated from inhibitor plasma was used as label without affinity purification. The capacity of the assay was high and the sensitivity for VIII: CAg was 0.002 U/ml. Using this assay it was possible to measure coagulation inactive VIII: CAg in samples from purification studies. Below 0.05 VIII: CAg U/ml these samples responded in parallel with standard plasma. Seven of 7 inhibitor antibodies tested were able to inhibit binding of peroxidase-conjugate in the VIII: CAg assay, and the inhibitory capacity correlated with coagulation inhibition as measured by the Bethesda method. Using the highest titered antibodies bound to a solid phase, VIII: CAg was isolated and identified in SDS-PAGE as a doublet with a molecular weight of 77-80 kD.
采用夹心酶联免疫吸附测定法(ELISA)检测凝血因子VIII促凝抗原(VIII: CAg)。以微孔板作为固相,使用从抑制剂血浆中分离的经辣根过氧化物酶缀合的IgG F(ab')2片段作为标记物,未进行亲和纯化。该检测方法的检测能力较高,对VIII: CAg的灵敏度为0.002 U/ml。利用该检测方法能够在纯化研究的样本中检测到无凝血活性的VIII: CAg。在VIII: CAg低于0.05 U/ml时,这些样本与标准血浆呈平行反应。所检测的7种抑制剂抗体中有7种能够在VIII: CAg检测中抑制过氧化物酶缀合物的结合,且抑制能力与采用贝塞斯达法测定的凝血抑制作用相关。使用与固相结合的效价最高的抗体,VIII: CAg在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)中被分离并鉴定为分子量为77 - 80 kD的双峰。